This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Five Prime Therapeutics, Inc.. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: The Innovations of Alessandro Palumbo
Introduction
Alessandro Palumbo is a notable inventor based in South San Francisco, CA. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. His work focuses on innovative solutions for cancer treatment, showcasing his commitment to advancing medical science.
Latest Patents
Alessandro Palumbo holds a patent for "B7-H4 antibodies and methods and use thereof." This patent provides antibodies and antigen-binding fragments that specifically bind to human B7-H4. The anti-B7-H4 antibodies are useful for detecting B7-H4, and immunohistochemistry (IHC) can be employed for this detection. Furthermore, the patent outlines methods for treating cancer where increased B7-H4 has been detected, by administering a therapeutic anti-B7-H4 antibody or antigen-binding fragment.
Career Highlights
Palumbo is currently associated with Five Prime Therapeutics, Inc., where he continues to work on groundbreaking research in the field of cancer therapeutics. His innovative approach and dedication to his work have positioned him as a key figure in the biotechnology sector.
Collaborations
Throughout his career, Alessandro has collaborated with esteemed colleagues such as Charles Kaplan and Majid Ghoddusi. These partnerships have fostered an environment of innovation and have contributed to the advancement of their shared goals in medical research.
Conclusion
Alessandro Palumbo's contributions to the field of biotechnology, particularly through his patent on B7-H4 antibodies, highlight his role as an influential inventor. His work not only advances scientific understanding but also holds promise for improving cancer treatment options.
